These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Finding the maximum safe dose level for heteroscedastic data. Tamhane AC; Logan BR J Biopharm Stat; 2004 Nov; 14(4):843-56. PubMed ID: 15587967 [TBL] [Abstract][Full Text] [Related]
5. A note on multiple testing procedures in dose finding. Bauer P Biometrics; 1997 Sep; 53(3):1125-8. PubMed ID: 9333343 [TBL] [Abstract][Full Text] [Related]
6. Step-down trend tests for identifying the minimum effective dose. Amaratunga D; Ge N J Biopharm Stat; 1998 Mar; 8(1):151-62. PubMed ID: 9547433 [TBL] [Abstract][Full Text] [Related]
7. Nonparametric procedures for simultaneous identification of the minimum effective dose in each of several groups. Jan SL; Chen YI J Biopharm Stat; 2004 Aug; 14(3):781-9. PubMed ID: 15468764 [TBL] [Abstract][Full Text] [Related]
8. A note on power and sample size calculations for the Kruskal-Wallis test for ordered categorical data. Fan C; Zhang D J Biopharm Stat; 2012; 22(6):1162-73. PubMed ID: 23075015 [TBL] [Abstract][Full Text] [Related]
9. A SAS(®) macro implementation of a multiple comparison post hoc test for a Kruskal-Wallis analysis. Elliott AC; Hynan LS Comput Methods Programs Biomed; 2011 Apr; 102(1):75-80. PubMed ID: 21146248 [TBL] [Abstract][Full Text] [Related]
10. Sequential method of estimating the LD50 using a modified up-and-down rule. Jung H; Choi SC J Biopharm Stat; 1994 Mar; 4(1):19-30. PubMed ID: 8019581 [TBL] [Abstract][Full Text] [Related]
11. Consonant closed likelihood ratio test procedures with application to dose-response study. Wang B; Cui X Stat Med; 2010 Nov; 29(25):2617-30. PubMed ID: 20740552 [TBL] [Abstract][Full Text] [Related]
12. Multiple test procedures using an upper bound of the number of true hypotheses and their use for evaluating high-dimensional EEG data. Hemmelmann C; Ziegler A; Guiard V; Weiss S; Walther M; Vollandt R J Neurosci Methods; 2008 May; 170(1):158-64. PubMed ID: 18279970 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the nonparametric estimation method in NONMEM VI. Savic RM; Kjellsson MC; Karlsson MO Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684 [TBL] [Abstract][Full Text] [Related]
14. Power comparisons of significance tests of location using scores, ranks, and modular ranks. Zimmerman DW Br J Math Stat Psychol; 2011 May; 64(Pt 2):233-43. PubMed ID: 21492130 [TBL] [Abstract][Full Text] [Related]
15. Multiple testing. Part I. Single-step procedures for control of general type I error rates. Dudoit S; van der Laan MJ; Pollard KS Stat Appl Genet Mol Biol; 2004; 3():Article13. PubMed ID: 16646791 [TBL] [Abstract][Full Text] [Related]
16. The analysis of small-sample multivariate data. Saranadasa H; Altan S J Biopharm Stat; 1998 Mar; 8(1):163-86. PubMed ID: 9547434 [TBL] [Abstract][Full Text] [Related]
17. Dunnett's many-to-one test and least square means. Shun Z; Silverberg A; Chang CK; Ouyang P J Biopharm Stat; 2003 Feb; 13(1):17-28. PubMed ID: 12635900 [TBL] [Abstract][Full Text] [Related]
18. Covariate adjustment for non-parametric tests for censored survival data. Li Z Stat Med; 2001 Jun; 20(12):1843-53. PubMed ID: 11406845 [TBL] [Abstract][Full Text] [Related]
20. A multiple comparison procedure to control the strong stagewise family error rate in comparing test treatments and a control. Chen M; Kianifard F J Biopharm Stat; 1997 Jul; 7(3):355-67. PubMed ID: 9252830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]